Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 442.00
Bid: 441.20
Ask: 442.20
Change: -7.40 (-1.65%)
Spread: 1.00 (0.227%)
Open: 450.60
High: 450.60
Low: 441.00
Prev. Close: 449.40
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre Close Trading Update

30 Sep 2014 07:00

RNS Number : 9341S
QinetiQ Group plc
30 September 2014
 



 

30 September 2014

 

QinetiQ Group plc

 

Pre Close Trading Update

 

Prior to entering its closed period, QinetiQ Group plc, the defence, security and aerospace company, reaffirms its previous guidance for Group performance in the full year to 31 March 2015.

 

EMEA Services

 

Utilisation levels and order intake in EMEA Services have been higher than at this stage last year. In addition profitability has been assisted by the completion of a final milestone on an international project as well as continuing productivity improvements and better project execution. QinetiQ Training, an "Explore" business, followed its success in the US where it has secured a position on two IDIQ contracts, with the award of a five-year, £33m contract for the continued provision of synthetic air and land mission training for the UK military principally at RAF Waddington in Lincoln, UK.

 

Global Products

 

The Global Products division has shorter order cycles than EMEA Services. The impact of the US military drawdown means that bookings have been slower than last year and visibility remains limited. As previously announced, the division will incur approximately $5m costs during H1 associated with separating from US Services infrastructure. The Global Products division continues to diversify its portfolio particularly into new sectors and earlier this month OptaSense announced that, working with Shell, it had established the world's first permanent fibre-optic Distributed Acoustic Sensing (DAS) in-well production flow monitoring system.

 

Balance sheet

 

Cash generation to date has been strong. A £150m share buyback was initiated on 28 May 2014 and at 26 September 2014 the Group had bought back 19m shares at a cost of £41m. The Group has also successfully re-financed its multi-currency revolving credit facility. The new five-year facility totals £225m and is undrawn.

 

Outlook

 

The outlook for the full year to 31 March 2015 is unchanged from that set out in the Interim Management Statement (IMS) dated 22 July 2014. Notwithstanding the strong performance in EMEA Services, the MOD transformation programme is likely to create some short-term uncertainty in the UK defence market, and the division's performance as a whole is expected to remain steady this year. At the same time there is a wide range of possible outcomes for the performance of Global Products as the division has a lumpy revenue profile which is dependent on the timing and shipment of key orders. Although newer products are recording notable milestones, the drawdown of American overseas military forces is expected to continue to depress demand for conflict-related products, and the division is unlikely to see significant benefits from the repositioning of its US operations until later in the financial year.

 

ENDS

 

Notes to Editors:

 

QinetiQ interim results for the half year ending 30 September 2014 will be announced on 20 November 2014.

 

A FTSE250 company, QinetiQ uses its world class knowledge, research and innovation to provide high-end technical expertise and advice, to customers in the global aerospace, defence and security markets. QinetiQ's unique position enables it to be a trusted partner to government organisations, predominantly in the UK and the US, including defence departments as well as other international customers in targeted sectors.

 

For more information see www.QinetiQ.com

 

Follow us on twitter @QinetiQ

 

Visit our blog at www.QinetiQ-blogs.com/QinetiQ

 

Download the QinetiQ investor relations app for iPad from the App Store.

 

For further information please contact:

 

Investor relations:

David Bishop, QinetiQ

+44 (0) 7920 108675

Media relations:

QinetiQ press office

+44 (0) 1252 393500

Liz Morley, Maitland

+44 (0) 20 7379 5151

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUKSRRSBAKUUR
Date   Source Headline
12th Jun 202410:11 amRNSDirector/PDMR Shareholding
12th Jun 20247:00 amRNSAnnual Financial Report
31st May 20244:00 pmRNSTotal Voting Rights
23rd May 20247:05 amRNSTransaction in Own Shares
23rd May 20247:00 amRNSQinetiQ Preliminary Results
22nd May 20247:00 amRNSTransaction in Own Shares
20th May 20247:00 amRNSTransaction in Own Shares
16th May 20247:00 amRNSTransaction in Own Shares
15th May 20247:00 amRNSTransaction in Own Shares
14th May 20245:45 pmRNSUpdate statement on 2023 AGM voting results
10th May 20244:17 pmRNSDirector/PDMR Shareholding
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
30th Apr 20244:00 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:01 amRNSDirectorate Change, Leadership Team appointments
16th Apr 20247:00 amRNSQinetiQ Group plc Fourth Quarter Trading Update
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20244:35 pmRNSDirector/PDMR Shareholding
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTotal Voting Rights
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSDirectorate Change
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20245:24 pmRNSHolding(s) in Company
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20244:05 pmRNSHolding(s) in Company
13th Mar 20244:00 pmRNSHolding(s) in Company
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20245:21 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.